Hey, NEO needs to acquire its self-designated chief competitor--CSI Labs. Remember how NEO was going to purchase CSI and it fell through. Well, now they've got this top-notch molecular lab to add to its resume. Only problem is that they still haven't figured out how to do FISH yet. Loser city. Better to buy Pathologic with all its attendant problems than to have purchased Clown, Inc. Maybe Pathologic sucks too, but NEO was wise to walk away from a disastrous purchase.